Skip to content

Clinical trials

Phase 4 Liver Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 4 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20072
20101
20121
20131
20161
20181
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Withdrawn3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation1
Dana-Farber Cancer Institute1
Fox Chase Cancer Center1
Lisa Sanderson Cox, PhD1
M.D. Anderson Cancer Center1
Massachusetts General Hospital1
Sirtex Medical1
The Methodist Hospital Research Institute1
University of California, San Diego1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms13
Carcinoma, Hepatocellular7
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Head and Neck Neoplasms2
Hypopharyngeal Neoplasms2
Kidney Neoplasms2
Laryngeal Neoplasms2
Leukemia2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.